This month will continue the discussion of healthcare reimbursement by third-party payers. We began last month with a review of the diagnosis-related groups (DRGs) and associated terminology. We will continue by reviewing how medical records are coded followed by the new MS-DRGs implemented in 2007.
The tool is particularly effective at illuminating which patients are at both ends of the severity spectrum, which can be helpful to emergency clinicians as they make their disposition decisions. Still, it is up to clinicians to consider the information provided, and then use their clinical judgment.
Because of COVID-19, many patients with dizziness may be seeking care virtually. It has become increasingly important for practitioners to be able to recognize whether there is a serious underlying cause via two-way video hookup.
Psychogenic nonepileptic seizures (PNES) can be frightening and debilitating. It is not uncommon for patients suffering from PNES to present to the ED for help. However, arriving at an accurate diagnosis in these cases can be tricky. Many patients with PNES are misdiagnosed, leading to frustration, morbidity, and (in many cases) harm related to inappropriate treatment.
The results of this study indicate that first-line genome sequencing in pediatric patients with suspected genetic white matter disease is more diagnostically efficient, defined as higher diagnostic efficacy and shorter time to diagnosis, than current standard of care approaches.
In this study, the investigators show the diagnostic value of video smartphone technology with regard to a seizure diagnosis as well as the ability of smartphone video to help distinguish epileptic seizures from nonepileptic events.
In this prospective, randomized trial, intravenous amoxicillin-clavulanate (dosed three times daily and given for two days) administered to patients admitted with out-of-hospital cardiac arrest due to a shockable rhythm reduced the incidence of early ventilator-associated pneumonia.